SciELO - Scientific Electronic Library Online

 
vol.28 issue1The influence of the Autonomic nervous system in the inflammatory response of sepsis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Arquivos de Medicina

On-line version ISSN 2183-2447

Abstract

LISBOA, Ana  and  BRITO, Iva. Systemic Lupus erythematosus and pregnancy: therapeutic implications. Arq Med [online]. 2014, vol.28, n.1, pp.18-24. ISSN 2183-2447.

Systemic lupus erythematosus (SLE) is a multissystemic autoimmune disease predominantly affecting women in reproductive age. In order to reach a successful pregnancy, conception ideally should occur when the disease is in remission, with an adequate planning and close monitoring by a multidisciplinary team. One of the critical issues in managing pregnant women with SLE is choosing the right medication to treat the mother without harming the gestation. The most used drugs in SLE during pregnancy are corticosteroids, non-steroidal anti-inflammatory drugs and hydroxychloroquine. Immunomodulator medications like azathioprine, cyclosporine and tacrolimus can also be used, as well as intravenous immunoglobulin. Potentially teratogenic drugs are contraindicated, including cyclophosphamide, methotrexate and mycophenolate mofetil. The purpose of the present article is to review the main recommendations in SLE therapy during pregnancy and breastfeeding.

Keywords : Lupus erythematosus systemic; pregnancy; therapeutics.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License